Agility Italy Earns GDP Certification for Pharma Logistics
Meets strict requirements for handling of essential medicines and health products
MILAN – November 25, 2019 – Agility, a leading global logistics provider, said that Agility Italy has earned Good Distribution Practice (GDP) certification, demonstrating its ability to meet stringent guidelines for proper storage, transport and distribution of medicinal products for human use.
GDP certification of Agility Italy, based in Milan, expands Agility’s continuously growing life sciences footprint, which includes 15 certified stations across Europe, Asia, Latin America and North America.
GDP practices are developed and maintained by the World Health Organization and European Union regulatory authorities to regulate the handling of essential medicines and health products.
“Pharma and life sciences logistics are highly specialized and complex. GDP certification means Agility Italy has proven its ability to maintain the safety, quality and integrity of the vital products in the pharmaceutical supply chain,” said Eric ten Kate, Agility Vice President of Life Sciences. “Agility’s life sciences specialists around the world are incredibly dedicated, and they have to be. Our practices, processes and policies ensure that consumers and their families get only the highest-quality medicines.”
Agility is a global logistics company with $5.1 billion in annual revenue and 26,000+ employees in more than 100 countries. It is one of the world’s top freight forwarding and contract logistics providers, and a leader and investor in technology to enhance supply chain efficiency. Agility is a pioneer in emerging markets and one of the largest private owners and developers of warehousing and light industrial parks in the Middle East, Africa and Asia. Agility’s subsidiary companies offer fuel logistics, airport services, commercial real estate and facilities management, customs digitization, and remote infrastructure services.